Ex-CIA officer facing jail in Italy claims Clinton, State

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
Ex-CIA officer facing jail in Italy claims Clinton, State Department ignored her pleas

A former CIA officer and diplomat who has repeatedly denied playing a role in one of the most notorious U.S. counterterrorism programs is set to become the only American held accountable for it -- and claims the Obama administration has abandoned her.

Sabrina De Sousa, who is stuck in Portugal and awaiting extradition to Italy over her alleged role in the rendition of a terror suspect years ago, claims the State Department has ignored repeated requests to intervene on her behalf. She and her lawyers are particularly critical of Hillary Clinton, who still has not commented on the case.

Mark S. Zaid, an attorney who previously worked with De Sousa, told FoxNews.com his firm made “multiple efforts” to reach out to the State Department -- specifically then-Secretary of State Clinton -- and that “every time we were completely rebuffed with silence.”

He said one of his letters was even "deceptively" classified “to limit my ability to create a public furor over how Sabrina had been and continues to be mistreated.”

De Sousa, a naturalized American from India, was arrested in Portugal last October and earlier this month lost her latest court bid to halt her extradition to Italy. She faces four years in prison there over her alleged role in the rendition of a suspected terrorist 13 years ago.

De Sousa has launched numerous unsuccessful bids over the years to clear her name, but has received little known help from the government she served for more than a decade.

If she’s sent to prison, she would become the first CIA officer and U.S. diplomat imprisoned over the controversial rendition program.

Implemented under President George W. Bush, the program transferred terror suspects to other countries for detention and interrogation. De Sousa, along with about two dozen other CIA agents and an Air Force official, were convicted in absentia in Italy in 2009 on kidnapping and other charges related to the abduction of Osama Mustapha Hassan Nasr, known also as Abu Omar, under the rendition program.

Omar, a radical cleric, was taken while walking down a street in Milan and flown to Egypt where he was held prisoner for four years without a trial before eventually being released. Omar claims during that time he was tortured.

Omar also was convicted in absentia in Italy of “criminal association for the purposes of international terrorism” and sentenced to six years in prison. Prosecutors claim he collaborated with 13 other suspected terrorists between 2000 and 2003 with the intent of carrying out terrorist attacks around the world.

Around the time of the rendition, De Sousa, 60, worked under diplomatic cover and was stationed in Milan.

On the specific day in question, though, De Sousa claims she was chaperoning her son’s school ski trip in northern Italy – about 200 miles from Milan.

De Sousa recently detailed her frustration over the situation to VICE. During the in-depth interview, she didn’t pull punches at who she thinks is hurting her shot at freedom.

“There needs to be an explanation instead of a no comment,” De Sousa said about Clinton’s careful avoidance of the issue. “She already has the issue of Benghazi, which was diplomatic. And now we have a U.S. diplomat going to prison, that’s two things.”

De Sousa believes Clinton could still do the right thing.

“I think the most important thing Secretary Clinton can do now is comment,” De Sousa told VICE. “So going in, if she becomes president, then at least everyone knows her position on it.”

A State Department official told FoxNews.com that they are aware of the De Sousa situation:

“We have seen reports that a Portuguese Court has acceded to the Italian government’s request for the extradition of Sabrina de Sousa. We refer you to the Italian and Portuguese governments for further information.”

De Sousa’s extradition was recently raised during a European Parliament hearing where a resolution was passed calling upon member states to formally investigate Europe’s role in U.S. renditions.

Ana Gomes, a member of the European Parliament, called De Sousa a “scapegoat” and said those truly responsible for renditions were being protected.

VICE also spoke with Abu Omar, who said he supports a pardon or immunity for De Sousa.

The irony isn’t lost on De Sousa.

“A former agency employee said to me – ‘How embarrassing is it going to be for the CIA when the terrorist starts to support you in this whole story?’” she reportedly said.

Glen Caplin, a spokesman for Clinton's campaign, told FoxNews.com that they "can not comment on the specifics of a case that is working its way through the legal systems of two other countries" and deferred "any questions to the U.S. government agencies."




Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 16

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 36

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Millrose Faces Securities Fraud Suit Amidst Decline

Updated Category News Views 148

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Continue Reading
John Wong's Decade as Estate Planning Specialist

Updated Category News Views 68

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 115

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 210

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 89

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading

Top 5 Most Recently Viewed Articles

Banco Santander to Redeem €187.6 Million CoCos Efficiently

Updated Category News Views 146

Banco Santander Approaches €187.6 Million CoCos Redemption BANCO SANTANDER S.A. has made a significant announcement regarding the redemption of its contingent convertible securities (CoCos). This decision, which is seen as a strategic move, highlights the bank's commitment to financial efficacy and investor satisfaction. Additionally, the redemption covers a total...

Continue Reading
Revolutionizing ADC Characterization with Biozen Native Columns

Updated Category News Views 480

Transforming Biotherapeutic Characterization First of its Kind in Biotherapeutic Antibody Characterization Phenomenex Inc., a leader in separation science technology, has launched Biozen Native RP-1 and RP-5 chromatography columns. These innovative products are engineered to meet the growing demand for effective characterization methods for Antibody-Drug Conjugates...

Continue Reading
TG Therapeutics to Attend the Upcoming Global Healthcare Event

Updated Category News Views 274

Participation in Global Healthcare Conference TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves as it prepares to take part in a prestigious healthcare event. Michael S. Weiss, the Chairman and CEO of the company, is scheduled to speak during the fireside chat at the Goldman Sachs Annual Global Healthcare Conference. This significant event will be hosted in Miami and...

Continue Reading
Ogury One: Revolutionizing Advertising in a Privacy-Centric World

Updated Category News Views 244

Ogury One: A New Era in Digital Advertising Ogury has launched its new client-facing platform, Ogury One, designed to revolutionize the way brands and agencies manage their advertising campaigns. As a leader in privacy-centric advertising solutions, Ogury One provides users with a comprehensive suite that facilitates seamless audience planning, activation, and reporting....

Continue Reading
Exploring Top Energy Stocks Benefiting from Industry Shifts

Updated Category News Views 124

Understanding the Shift in Energy Supply Dynamics The global energy landscape is undergoing significant changes, particularly as liquefied natural gas (LNG) supply anticipated an increase. Analysts believe that the next few years will see substantial growth in LNG, especially in response to evolving demand and new technologies. As the market adjusts, smart investors are...

Continue Reading